Re-evaluating testosterone therapy: new insights for men with familial prostate cancer risk.
作者信息
Cakir Omer Onur, Castiglione Fabio
机构信息
Urology, King's College London, London, UK.
Urology, King's College London Faculty of Life Sciences & Medicine, London, UK.
出版信息
BMJ Oncol. 2025 Mar 6;4(1):e000635. doi: 10.1136/bmjonc-2024-000635. eCollection 2025.
Abstract
摘要
相似文献
1
Re-evaluating testosterone therapy: new insights for men with familial prostate cancer risk.重新评估睾酮治疗：对有家族性前列腺癌风险男性的新见解。
BMJ Oncol. 2025 Mar 6;4(1):e000635. doi: 10.1136/bmjonc-2024-000635. eCollection 2025.
2
Testosterone Therapy in Men With Prostate Cancer.前列腺癌男性的睾酮治疗
Eur Urol. 2016 May;69(5):894-903. doi: 10.1016/j.eururo.2015.12.005. Epub 2015 Dec 21.
3
[Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
Medwave. 2015 Apr 6;15(3):e6115. doi: 10.5867/medwave.2015.03.6115.
4
Clinical evaluation and treatment in men with low testosterone levels and prostate cancer.睾酮水平低下的男性前列腺癌患者的临床评估与治疗
Actas Urol Esp (Engl Ed). 2024 Jul-Aug;48(6):410-415. doi: 10.1016/j.acuroe.2023.12.001. Epub 2023 Dec 13.
5
Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: Surveillance, Epidemiology, and End Results-Medicare 2007-2015.评估诊断前使用他汀类药物和睾酮替代疗法对患有激素相关癌症的老年男性死亡率结局的影响：监测、流行病学和最终结果-2007-2015 年医疗保险。
Andrology. 2024 Nov;12(8):1697-1711. doi: 10.1111/andr.13616. Epub 2024 Feb 29.
6
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.《男性性腺功能减退症睾酮治疗：内分泌学会临床实践指南》。
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744. doi: 10.1210/jc.2018-00229.
7
Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.睾酮替代疗法用于前列腺癌高危性腺功能减退男性：前列腺上皮内瘤变男性患者1年治疗结果
J Urol. 2003 Dec;170(6 Pt 1):2348-51. doi: 10.1097/01.ju.0000091104.71869.8e.
8
Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.睾酮治疗对前列腺癌主动监测及确定性治疗后的影响
Curr Urol Rep. 2017 Jul;18(7):49. doi: 10.1007/s11934-017-0695-6.
9
Testosterone Therapy Among Prostate Cancer Survivors.前列腺癌幸存者的睾酮治疗。
Sex Med Rev. 2016 Oct;4(4):376-88. doi: 10.1016/j.sxmr.2016.06.005. Epub 2016 Jul 27.
10
Prostate cancer risk in testosterone-treated men.接受睾酮治疗的男性患前列腺癌的风险。
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):261-6. doi: 10.1016/j.jsbmb.2006.09.032.
本文引用的文献
1
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.男性性腺功能减退症患者接受睾酮替代治疗期间的前列腺安全事件：一项随机临床试验。
JAMA Netw Open. 2023 Dec 1;6(12):e2348692. doi: 10.1001/jamanetworkopen.2023.48692.
2
Testosterone Therapy for High-risk Prostate Cancer Survivors: A Systematic Review and Meta-analysis.高危前列腺癌幸存者的睾酮治疗：一项系统评价和荟萃分析。
Urology. 2019 Apr;126:16-23. doi: 10.1016/j.urology.2018.07.064. Epub 2018 Sep 21.
3
Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis.内源性和外源性睾酮与前列腺癌风险及前列腺特异性抗原（PSA）水平升高：一项荟萃分析。
BJU Int. 2016 Nov;118(5):731-741. doi: 10.1111/bju.13417. Epub 2016 Feb 24.
4
Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.睾酮在前列腺癌细胞系氧化应激下促进 DNA 损伤反应。
Prostate. 2012 Sep 15;72(13):1407-11. doi: 10.1002/pros.22492. Epub 2012 Jan 30.
5
Testosterone therapy in men with untreated prostate cancer.未治疗前列腺癌男性的睾酮治疗。
J Urol. 2011 Apr;185(4):1256-60. doi: 10.1016/j.juro.2010.11.084. Epub 2011 Feb 22.
6
Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.前列腺癌研究。I. 去势、雌激素及雄激素注射对前列腺转移性癌血清磷酸酶的影响。
CA Cancer J Clin. 1972 Jul-Aug;22(4):232-40. doi: 10.3322/canjclin.22.4.232.
Zotero 插件